HPV co-factors related to the development of cervical cancer: Results from a population-based study in Costa Rica

British Journal of Cancer

Volumn 84, Issue 9, 2001, Pages 1219-1226

  Hildesheim, A ^a   Herrero, R ^b   Castle, P E ^a   Wacholder, S ^a   Bratti, M C ^b   Sherman, M E ^a,c   Lorincz, A T ^d   Burk, R D ^e   Morales, J ^b   Rodriguez, A C ^b   Helgesen, K ^f   Alfaro, M ^b   Hutchinson, M ^g   Balmaceda, I ^b   Greenberg, M ^h   Schiffman, M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CAJA COSTARRICENSE DE SEGURO SOCIAL   (Costa Rica)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d Digene Corporation   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f INFORMATION MANAGEMENT SERVICES INC   (United States)

^g WOMEN AND INFANTS HOSPITAL   (United States)

^h Omnia Inc   (United States)

Author keywords

Cancer; Cervix; Human papillomavirus; Parity; Smoking

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTRACEPTIVE DEVICE; CONTROLLED STUDY; COSTA RICA; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MULTIPARA; ORAL CONTRACEPTION; PARITY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COSTA RICA; FEMALE; HUMANS; INCIDENCE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PARITY; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SMOKING; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 17844406609     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1779     Document Type: Article

References (41)

1. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice
2. Integration of high risk human papillomavirus DNA is linked to the down-regulation of class I human leucocyte antigens by steroid hormones in cervical tumour cells
3. Contraceptive and reproductive risks for cervical dysplasia in southwestern hispanic and non-hispanic white women
4. Variance calculations and confidence intervals for estimates of the attributable risk based on logistic models
5. Risk factors for cervical cancer in Colombia and Spain
6. Prevalence of HPV DNA in cervical cancer: A worldwide perspective
7. Statistical methods in cancer research: The analysis of case-control studies
8. Parity as a risk factor for cervical cancer
9. The viral origin of cervical cancer in Rabat, Morocco
10. Risk factors for cervical cancer in Thailand: A case-control study
11. Human papillomavirus testing by Hybrid Capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance
12. Symptomatic and asymptomatic cervical infections with human papillomavirus during pregnancy
13. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period
14. Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy
15. Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri
16. Injectable contraceptives and risk of invasive cervical cancer: Evidence of an association
17. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: The Guanacaste project
18. A population-based study of human papillomavirus infection and all grades of cervical neoplasia in rural Costa Rica
19. Persistence of type-specific human papillomavirus infection among cytologically normal women in Portland, Oregon
20. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia
21. Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: A review
22. Human papillomavirus-The most significant risk determinant of cervical intraepithelial neoplasia
23. Different risk factor patterns for high-grade and low-grade intraepithelial lesions of the cervix among HPV-positive and HPV-negative young women
24. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells
25. Human papillomavirus type 16 expression in cervical keratinocytes: Role of progesterone and glucocorticoid hormones
26. Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer
27. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia
28. Causes of cervical cancer in the Philippines: A case-control study
29. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study
30. Combined effect of smoking and human papillomavirus type 16 infection in cervical carcinogenesis
31. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA
32. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers
33. Increased frequency of detection of human papillomavirus deoxtribonucleic acid in exfoliated cervical cells during pregnancy
34. Case-control study of human papillomaviruses and cervical cancer in Latin America
35. Cigarete smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women
36. The epidemiology of cervical carcinogenesis
37. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia
38. Cervical cancer
39. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica
40. Increased prevalence of human papillomavirus in the lower genital tract of pregnant women
41. The association between pregnancy and human papilloma virus prevalence